Senti Biosciences Announces 1-for-33 Reverse Stock Split
Senti Biosciences Holdings (SNTI) has announced that its Board of Directors has approved a one-for-thirty-three reverse stock split of its common stock. The par value per share is set at $0.0001. Reverse stock splits are typically implemented by companies to increase their per-share trading price, often to maintain compliance with exchange listing requirements or to improve the stock's visibility among institutional investors.

Tickers: $SNTI
Topics: equity restructuring reverse stock split
Read the full article at Seeking Alpha
Part of the story Sandisk Announces 8-for-1 Forward Stock Split (4 articles)